To address these factors, we investigated the antitumor and immunomodulatory properties of 177Lu-NM600 and 225Ac-NM600 in syngeneic TRAMP-C1 and Myc-CaP murine PCa models. The gene discussed is MYC; the disease is posterior cortical atrophy.